Who Paid My Doc
A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral Mln9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov NCT01850524
Research payments
$940,786
Through program year 2023, $940,786 in research payments was reported against A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral Mln9708 Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma, across 309 payments, paid by Takeda Pharmaceuticals U.S.A., Inc..
- Paid by
- Takeda Pharmaceuticals U.S.A., Inc.
- ClinicalTrials.gov
- NCT01850524
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $28,976 | 7 |
| 2022 | Research | $693,541 | 148 |
| 2021 | Research | $218,269 | 154 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Bruce Porterfield Green Valley, AZ Named on 40 payments
- Hakan Kaya Spokane, WA Named on 16 payments
- Sagar Lonial Atlanta, GA Named on 14 payments
- Bertrand Anz Chattanooga, TN Named on 13 payments
- Albert Dekker Mission Hills, CA Named on 12 payments
- Caitlin Costello La Jolla, CA Named on 12 payments
- Kelly Godby Birmingham, AL Named on 10 payments
- Steven Kim Fullerton, CA Named on 10 payments
- Seema Naik Hershey, PA Named on 9 payments
- Jesus Berdeja Nashville, TN Named on 9 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.